The Antiviral Activity of Andrographolide, the Active Metabolite from Andrographis paniculata (Burm. f.) Wall. ex Nees. against SARS-CoV-2 by Using Bio- and Chemoinformatic Tools

Q3 Multidisciplinary
T. Pitakbut
{"title":"The Antiviral Activity of Andrographolide, the Active Metabolite from Andrographis paniculata (Burm. f.) Wall. ex Nees. against SARS-CoV-2 by Using Bio- and Chemoinformatic Tools","authors":"T. Pitakbut","doi":"10.48048/wjst.2020.9728","DOIUrl":null,"url":null,"abstract":"Due to the severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 outbreak, the virus has been wildly spread throughout the world and the number of infected patients has rapidly increased More importantly, neither the official drug treatment nor the vaccine has been officially offered These have considerably increased the public concerns internationally and nationally Recently, there has been one question raised in the Thai society;“Could a common Thai herbal medicine namely Andrographis paniculata be used against SARS-CoV-2 infection?” It is well-known that the plant has antiviral properties against wild ranges of viruses and the active metabolite is andrographolide To date, there have only been a few studies investigating the anti-SARS-CoV-2 activity from andrographolide To provide a better understanding, this study was conducted by applying the advanced techniques in both computational biology and chemistry to evaluate the anti-SARS-CoV-2 potential of andrographolide In this study, andrographolide was tested against two key enzymes of SAR-CoV-2 namely 3C main proteinase and RNA dependent RNA polymerase The result here indicated that andrographolide could only inhibit the SARS-CoV-2 3C main proteinase as strong as lopinavir (the standard medicine), which has been recommended as the drug of choice to treat SARS-CoV-2 patient © 2020, Walailak University All rights reserved","PeriodicalId":38275,"journal":{"name":"Walailak Journal of Science and Technology","volume":"17 1","pages":"851-866"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Walailak Journal of Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48048/wjst.2020.9728","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Multidisciplinary","Score":null,"Total":0}
引用次数: 5

Abstract

Due to the severe acute respiratory syndrome coronavirus 2 or SARS-CoV-2 outbreak, the virus has been wildly spread throughout the world and the number of infected patients has rapidly increased More importantly, neither the official drug treatment nor the vaccine has been officially offered These have considerably increased the public concerns internationally and nationally Recently, there has been one question raised in the Thai society;“Could a common Thai herbal medicine namely Andrographis paniculata be used against SARS-CoV-2 infection?” It is well-known that the plant has antiviral properties against wild ranges of viruses and the active metabolite is andrographolide To date, there have only been a few studies investigating the anti-SARS-CoV-2 activity from andrographolide To provide a better understanding, this study was conducted by applying the advanced techniques in both computational biology and chemistry to evaluate the anti-SARS-CoV-2 potential of andrographolide In this study, andrographolide was tested against two key enzymes of SAR-CoV-2 namely 3C main proteinase and RNA dependent RNA polymerase The result here indicated that andrographolide could only inhibit the SARS-CoV-2 3C main proteinase as strong as lopinavir (the standard medicine), which has been recommended as the drug of choice to treat SARS-CoV-2 patient © 2020, Walailak University All rights reserved
穿心莲活性代谢产物穿心莲内酯的抗病毒活性研究。f。)墙。交货需要雇。利用生物和化学信息学工具对抗SARS-CoV-2
由于严重急性呼吸综合征冠状病毒2型或严重急性呼吸系统综合征冠状病毒-2型的爆发,该病毒在世界各地广泛传播,感染患者人数迅速增加。更重要的是,官方药物治疗和疫苗都没有正式提供。这些大大增加了国际和国内公众的担忧。最近,泰国社会提出了一个问题;“一种常见的泰国草药,即穿心莲,可以用来对抗严重急性呼吸系统综合征冠状病毒2型感染吗?”众所周知,这种植物对野生病毒具有抗病毒特性,其活性代谢产物是穿心莲内酯。到目前为止,只有少数研究调查穿心莲的抗严重急性呼吸系冠状病毒2型活性,本研究通过应用计算生物学和化学的先进技术来评估穿心莲内酯的抗严重急性呼吸系统综合征冠状病毒2型的潜力。在本研究中,穿心莲内酯对严重急性呼吸系统综合征冠状病毒2型的两种关键酶,即3C主蛋白酶和RNA依赖性RNA聚合酶进行了测试。这里的结果表明,穿心莲苷只能像洛匹那韦(标准药物)一样强烈地抑制严重急性呼吸系统冠状病毒2型3C主蛋白酶,该药物已被推荐为治疗严重急性呼吸综合征冠状病毒2中患者的首选药物©2020,瓦利拉克大学版权所有
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Walailak Journal of Science and Technology
Walailak Journal of Science and Technology Multidisciplinary-Multidisciplinary
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊介绍: The Walailak Journal of Science and Technology (Walailak J. Sci. & Tech. or WJST), is a peer-reviewed journal covering all areas of science and technology, launched in 2004. It is published 12 Issues (Monthly) by the Institute of Research and Innovation of Walailak University. The scope of the journal includes the following areas of research : - Natural Sciences: Biochemistry, Chemical Engineering, Chemistry, Materials Science, Mathematics, Molecular Biology, Physics and Astronomy. -Life Sciences: Allied Health Sciences, Biomedical Sciences, Dentistry, Genetics, Immunology and Microbiology, Medicine, Neuroscience, Nursing, Pharmaceutics, Psychology, Public Health, Tropical Medicine, Veterinary. -Applied Sciences: Agricultural, Aquaculture, Biotechnology, Computer Science, Cybernetics, Earth and Planetary, Energy, Engineering, Environmental, Food Science, Information Technology, Meat Science, Nanotechnology, Plant Sciences, Systemics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信